Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)

Phase 3

Completed

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2020/05/025156
• Lead Sponsor: Central Council for Research in Ayurvedic Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-11-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1.Patients of 18-60 yrs of age, clinically diagnosed with corona virus disease 2019 by RTPCR test coming under stage I- mild (Early infection)- Group A, B, C as per TREATMENT PROTOCOL FOR CONFIRMED COVID-19 PATIENTS (Maharashtra Health Services_15 April 2020.)

2.Participants who can take medicines orally.

3.Patients willing to provide signed informed consent.

Exclusion Criteria

1.Pregnant, Lactating women, patients with CKD (Chronic Kidney Disease).

2.Not willing to participate in the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified